AilanthoneCAS# 981-15-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 981-15-7 | SDF | Download SDF |
PubChem ID | 72965 | Appearance | Powder |
Formula | C20H24O7 | M.Wt | 376.4 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | DMSO : 83.3 mg/mL (221.31 mM; Need warming) | ||
SMILES | CC1=CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O | ||
Standard InChIKey | WBBVXGHSWZIJST-RLQYZCPESA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Ailanthone has anti-inflammatory, anti-HIV, anti-malarial, anti-allergic, antiulcer and antimicrobial activities; it also has potent antineoplastic activity against hepatocellular carcinoma (HCC), it can inhibit huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Ailanthone has significant pre-emergence herbicide activity , is directly correlated to Ailanthone concentration. |
Targets | HIV | Antifection |
In vitro | Herbicidal effects under field conditions of Ailanthus altissima bark extract, which contains ailanthone.[Reference: WebLink]Plant & Soil, 2003, 256(1):85-99.
|
In vivo | Antitumor activity of novel ailanthone derivatives in vitro and in vivo.[Pubmed: 3178149]Anticancer Res. 1988 Jul-Aug;8(4):573-9.The antitumor activities of two Ailanthone derivatives with 15 beta-acyloxy side chains were investigated.
Antiamebic properties of some derivatives of ailantone and quassin.[Pubmed: 7227501]Farmaco Sci. 1981 Feb;36(2):116-22.Owing to its high toxicity, Ailanthone, one of the most potent in vivo amoebicidal drugs of natural origin, cannot be safely employed in clinical trials. With the aim of obtaining a compound with a better therapeutic index and of studying possible relationships between biological activity and chemical structure, many derivatives of Ailanthone and of the chemically related, although biologically inactive, quassin have been prepared and tested. |
Kinase Assay | Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo.[Pubmed: 26525771]Sci Rep. 2015; 5: 16185.While searching for natural anti-hepatocellular carcinoma (HCC) components in Ailanthus altissima, we discovered that Ailanthone had potent antineoplastic activity against HCC. However, the molecular mechanisms underlying the antitumor effect of Ailanthone on HCC have not been examined. In this study, the antitumor activity and the underlying mechanisms of Ailanthone were evaluated in vitro and in vivo. |
Structure Identification | Nat Prod Commun. 2011 May;6(5):593-6.Herbicide activity of extracts from Ailanthus altissima (Simaroubaceae).[Pubmed: 21615014]The purpose of the present study was to isolate and characterize Ailanthone-rich materials from the bark of the deciduous tree Ailanthus altissima (Mill.) Swingle and to assess their herbicide activity on selected herbaceous species.
|
Ailanthone Dilution Calculator
Ailanthone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6567 mL | 13.2837 mL | 26.5675 mL | 53.135 mL | 66.4187 mL |
5 mM | 0.5313 mL | 2.6567 mL | 5.3135 mL | 10.627 mL | 13.2837 mL |
10 mM | 0.2657 mL | 1.3284 mL | 2.6567 mL | 5.3135 mL | 6.6419 mL |
50 mM | 0.0531 mL | 0.2657 mL | 0.5313 mL | 1.0627 mL | 1.3284 mL |
100 mM | 0.0266 mL | 0.1328 mL | 0.2657 mL | 0.5313 mL | 0.6642 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lupinalbin A
Catalog No.:BCN8191
CAS No.:98094-87-2
- Lomefloxacin HCl
Catalog No.:BCC4673
CAS No.:98079-52-8
- Brompheniramine hydrogen maleate
Catalog No.:BCC4515
CAS No.:980-71-2
- Pyrazinamide
Catalog No.:BCC4932
CAS No.:98-96-4
- Nicotinamide
Catalog No.:BCN1025
CAS No.:98-92-0
- Acetophenone
Catalog No.:BCN8300
CAS No.:98-86-2
- H-Pyr-OH
Catalog No.:BCC3328
CAS No.:98-79-3
- Terpineol
Catalog No.:BCN3595
CAS No.:98-55-5
- 4-Aminophenylarsonic acid
Catalog No.:BCC8688
CAS No.:98-50-0
- Benzenesulfonic acid
Catalog No.:BCC8846
CAS No.:98-11-3
- Methyl (E)-3'-hydroxy-4'-methoxycinnamate
Catalog No.:BCN1294
CAS No.:97966-29-5
- Leachianone A
Catalog No.:BCN4530
CAS No.:97938-31-3
- Difloxacin HCl
Catalog No.:BCC3764
CAS No.:98106-17-3
- 5,2',6'-Trihydroxy-6,7,8-trimethoxyflavone
Catalog No.:BCN1293
CAS No.:98187-98-5
- Eltoprazine hydrochloride
Catalog No.:BCC5422
CAS No.:98224-03-4
- Eltoprazine
Catalog No.:BCC5421
CAS No.:98206-09-8
- Hupehenine
Catalog No.:BCN2617
CAS No.:98243-57-3
- Isotanshinone II
Catalog No.:BCN3002
CAS No.:98249-39-9
- Boc-D-2-Pal-OH
Catalog No.:BCC2654
CAS No.:98266-32-1
- Boc-D-3-Pal-OH
Catalog No.:BCC2652
CAS No.:98266-33-2
- Nodulisporic acid C2
Catalog No.:BCC8326
CAS No.:
- Finasteride
Catalog No.:BCC2491
CAS No.:98319-26-7
- Metoprolol Succinate
Catalog No.:BCC6519
CAS No.:98418-47-4
- Myelin Basic Protein (68-82), guinea pig
Catalog No.:BCC1020
CAS No.:98474-59-0
Herbicide activity of extracts from Ailanthus altissima (Simaroubaceae).[Pubmed:21615014]
Nat Prod Commun. 2011 May;6(5):593-6.
The purpose of the present study was to isolate and characterize Ailanthone-rich materials from the bark of the deciduous tree Ailanthus altissima (Mill.) Swingle and to assess their herbicide activity on selected herbaceous species. Ailanthone-rich fractions were obtained from A. altissima bark by extraction with dichloromethane and ethyl acetate and subsequent purification of these crude extracts, and of the remaining water mixture after solvent extraction, by means of gel permeation chromatography. A number of fractions were isolated and characterized for Ailanthone content. A dichloromethane fraction was shown to contain 92% w/w of Ailanthone, as demonstrated by HPLC and NMR analysis. A significant pre-emergence herbicide activity was found for most of the extracts which was directly correlated to Ailanthone concentration. A remarkable combined pre- and post-emergence herbicide activity was found for a specific fraction. These results indicate that the bark of A. altissima may represent an interesting source for the production of natural herbicides for use in agriculture.
Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo.[Pubmed:26525771]
Sci Rep. 2015 Nov 3;5:16185.
While searching for natural anti-hepatocellular carcinoma (HCC) components in Ailanthus altissima, we discovered that Ailanthone had potent antineoplastic activity against HCC. However, the molecular mechanisms underlying the antitumor effect of Ailanthone on HCC have not been examined. In this study, the antitumor activity and the underlying mechanisms of Ailanthone were evaluated in vitro and in vivo. Mechanistic studies showed that Ailanthone induced G0/G1-phase cell cycle arrest, as indicated by decreased expression of cyclins and CDKs and increased expression of p21 and p27. Our results demonstrated that Ailanthone triggered DNA damage characterized by activation of the ATM/ATR pathway. Moreover, Ailanthone-induced cell death was associated with apoptosis, as evidenced by an increased ratio of cells in the subG1 phase and by PARP cleavage and caspase activation. Ailanthone-induced apoptosis was mitochondrion-mediated and involved the PI3K/AKT signaling pathway in Huh7 cells. In vivo studies demonstrated that Ailanthone inhibited the growth and angiogenesis of tumor xenografts without significant secondary adverse effects, indicating its safety for treating HCC. In conclusion, our study is the first to report the efficacy of Ailanthone against Huh7 cells and to elucidate its underlying molecular mechanisms. These findings suggest that Ailanthone is a potential agent for the treatment of liver cancer.
[Antiamebic properties of some derivatives of ailantone and quassin].[Pubmed:7227501]
Farmaco Sci. 1981 Feb;36(2):116-22.
Owing to its high toxicity, Ailanthone, one of the most potent in vivo amoebicidal drugs of natural origin, cannot be safely employed in clinical trials. With the aim of obtaining a compound with a better therapeutic index and of studying possible relationships between biological activity and chemical structure, many derivatives of Ailanthone and of the chemically related, although biologically inactive, quassin have been prepared and tested.
Antitumor activity of novel ailanthone derivatives in vitro and in vivo.[Pubmed:3178149]
Anticancer Res. 1988 Jul-Aug;8(4):573-9.
The antitumor activities of two Ailanthone derivatives with 15 beta-acyloxy side chains were investigated. The cytotoxic activity of 11 beta, 20-epoxy-1 beta, 11 alpha, 12 alpha-trihydroxy-15-beta-[E)-3-methyl-2-octenoyl) oxypicras-3,13(21)-diene-2,16-dione (SUN2071) and 11 beta, 20-epoxy-1 beta, 11 alpha, 12 alpha-trihydroxy-15 beta-[E)-2-undecenoyl) oxypicras-3,13(21)-diene-2,16-dione (SUN0237) was close to that of bruceantin and vincristine. SUN2071 was shown to be a potent inhibitor of protein synthesis in L1210 cultured cells. When administered i.p. to i.p. inoculated P388 leukemia mice, daily treatment with SUN2071 and SUN0237 significantly increased the lifespan (increases in lifespan in excess of 100% were achieved). These increases were comparable to those achieved with vincristine. The therapeutic ratio of SUN2071 was also close to that of vincristine. However, the compounds were ineffective when administered as a single injection. Daily i.p. treatment with SUN2071 demonstrated significant tumor growth inhibition in mice inoculated s.c. with colon-38 and moderate activity against i.p. L1210 leukemia and i.p. B16 melanoma. The compounds were ineffective when tested against the Lewis lung carcinoma and colon-26. In a preliminary toxicological study, SUN2071 at a therapeutic dose in daily consecutive i.p. injection produced leucopenia.